Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
In 2013, the first case of human infection with an avian influenza A virus (H7N9) was reported in China, and the human infection with this virus has continued as of 2016. At the request of the WHO, we have successfully developed candidate reassortant vaccine virus using A/Anhui/1/2013 and the high e...
Main Authors: | Yasushi Suzuki, Takato Odagiri, Masato Tashiro, Eri Nobusawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4959774?pdf=render |
Similar Items
-
Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014
by: Ikuyo Takayama, et al.
Published: (2016-03-01) -
Assessment of trivalent live influenza vaccines in MDCK cell line
by: G. Landgraf, et al.
Published: (2021-01-01) -
Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan.
by: Akira Ainai, et al.
Published: (2015-01-01) -
The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.
by: Xu-Sheng Zhang, et al.
Published: (2014-01-01) -
Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets.
by: Min-Yuan Chia, et al.
Published: (2015-01-01)